BIOA-B.ST
Price:
$149.9
Market Cap:
$12.84B
BioArctic AB (publ), a research-intensive biopharmaceutical company, develops biological drugs for patients with neurodegenerative disorders in Sweden. The company develops BAN2401, an immunotherapy, which is in Phase III clinical trials targeting the toxic amyloid-beta oligomers/protofibrils in Alzheimer's disease; and is in preclinical trials for treating Down's syndrome with dementia and traumatic brain injury, as well as BAN2401 Back-up, a disease modifying antibody treatment that is in late preclinical Phase for patients with early Alzheimer's disease. It also develops ABBV-0805, a monoclonal antibody for treating Parkinson's disease; and SC0806, a biodegradable device that is in Phase ...[Read more]
Industry
Biotechnology
IPO Date
2017-10-12
Stock Exchange
STO
Ticker
BIOA-B.ST
According to BioArctic AB (publ)’s latest financial reports and current stock price. The company's current ROE is -8.62%. This represents a change of 230.62% compared to the average of -2.61% of the last 4 quarters.
The mean historical ROE of BioArctic AB (publ) over the last ten years is 16.10%. The current -8.62% ROE has changed -153.53% with respect to the historical average. Over the past ten years (40 quarters), BIOA-B.ST's ROE was at its highest in in the December 2016 quarter at 123.38%. The ROE was at its lowest in in the June 2023 quarter at -10.29%.
Average
16.10%
Median
3.43%
Minimum
-15.19%
Maximum
94.77%
Discovering the peaks and valleys of BioArctic AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.67%
Maximum Annual ROE = 94.77%
Minimum Annual Increase = -1640.74%
Minimum Annual ROE = -15.19%
Year | ROE | Change |
---|---|---|
2023 | 21.90% | -1640.74% |
2022 | -1.42% | -90.64% |
2021 | -15.19% | 101.13% |
2020 | -7.55% | -183.18% |
2019 | 9.08% | -75.79% |
2018 | 37.50% | 1.47% |
2017 | 2.38% | -97.49% |
2016 | 94.77% | 2.67% |
The current ROE of BioArctic AB (publ) (BIOA-B.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.76%
5-year avg
1.36%
10-year avg
16.10%
BioArctic AB (publ)’s ROE is greater than Oncopeptides AB (publ) (-280.43%), greater than Calliditas Therapeutics AB (publ) (-210.18%), less than Camurus AB (publ) (10.44%), less than Hansa Biopharma AB (publ) (242.32%), greater than Cantargia AB (publ) (-158.17%),
Company | ROE | Market cap |
---|---|---|
-280.43% | $438.37M | |
-210.18% | $11.24B | |
10.44% | $35.52B | |
242.32% | $2.22B | |
-158.17% | $545.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioArctic AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioArctic AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioArctic AB (publ)'s ROE?
How is the ROE calculated for BioArctic AB (publ) (BIOA-B.ST)?
What is the highest ROE for BioArctic AB (publ) (BIOA-B.ST)?
What is the 3-year average ROE for BioArctic AB (publ) (BIOA-B.ST)?
What is the 5-year average ROE for BioArctic AB (publ) (BIOA-B.ST)?
How does the current ROE for BioArctic AB (publ) (BIOA-B.ST) compare to its historical average?